Perimeter Solutions reported strong top-line expansion for the full year 2025, with net sales climbing 16% to $652.9 million, while Adjusted EBITDA increased 18% to $331.7 million. The revenue performance reflects continued demand across the company's operating segments and demonstrates underlying operational momentum.
Despite revenue gains, the company reported a net loss of $206.4 million, or $1.37 per diluted share, compared to a $5.9 million loss in 2024. The significant net loss was primarily attributable to $435.2 million in founders advisory fees incurred during the period, a non-recurring charge that materially impacted bottom-line results. The gap between Adjusted EBITDA growth and net income reflects the impact of non-operating expenses on the company's financial position.
Looking ahead, Perimeter Solutions completed the acquisition of Medical Manufacturing Technologies for $685 million in January 2026, a strategic transaction designed to expand capabilities within the company's Specialty Products segment. The acquisition represents a significant capital deployment and positions the company to pursue additional market opportunities in its target sectors.